Page Content
#ffffff
Anonymous user
On
Authenticated user
On
Premium
On
Paid / Sponsored
On
Featured
Off
Key highlights
- Automated insulin delivery reduced HbA1c by 0.8% vs control in both groups (P<0.001 high, P=0.02 low).
- Similar benefits were observed in participants aged ≥65 years.
- Findings suggest CMS requirement for low C-peptide as prerequisite for automated insulin delivery (AID) coverage is not justified.
Source
Hirsch IB, Kudva YC, Ahn DT, et al. Adults With Type 2 Diabetes Benefit From Automated Insulin Delivery Irrespective of C-Peptide Level. Diabetes Care. Published online September 15, 2025. doi:10.2337/dc25-1125
Thumbnail
Schedule Date & Time
Speciality
Currency
Sub Speciality
Sub Sub Speciality
Short Description
Trial findings challenge CMS coverage rule requiring low C-peptide for pump eligibility.
User Segments
Release Date
Featured Order
0
Is Paid
0